Research Articles
Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer Progression
Mariana C. Silva, Ângela Fernandes, Maria Oliveira, Carlos Resende, Alexandra Correia, Julio C. de-Freitas-Junior, Aonghus Lavelle, Jéssica Andrade-da-Costa, Magdalena Leander, Helena Xavier-Ferreira, José Bessa, Carina Pereira, Rui M. Henrique, Fátima Carneiro, Mário Dinis-Ribeiro, Ricardo Marcos-Pinto, Margarida Lima, Bernd Lepenies, Harry Sokol, José C. Machado, Manuel Vilanova and Salomé S. Pinho
Mariana C. Silva
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Ângela Fernandes
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Maria Oliveira
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Carlos Resende
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Alexandra Correia
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Julio C. de-Freitas-Junior
3Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Aonghus Lavelle
4Sorbonne Université, INSERM, Saint-Antoine Research Center (CRSA), Paris, France.
Jéssica Andrade-da-Costa
3Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Magdalena Leander
5Department of Hematology, Hospital Center of Porto, Porto, Portugal.
6Multidisciplinary Unit for Biomedical Research, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Helena Xavier-Ferreira
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
José Bessa
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Carina Pereira
7CINTESIS – Centre for Health Technology and Services Research, University of Porto, Porto, Portugal.
8Molecular Oncology and Viral Pathology Group, IPO Porto Research Group (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
Rui M. Henrique
9Department of Pathology and Cancer Biology and Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
10Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Fátima Carneiro
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
11Department of Pathology, Hospital Center of São João, Porto, Portugal.
12Faculty of Medicine, University of Porto, Porto, Portugal.
Mário Dinis-Ribeiro
7CINTESIS – Centre for Health Technology and Services Research, University of Porto, Porto, Portugal.
13Department of Gastroenterology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
Ricardo Marcos-Pinto
2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
14Department of Gastroenterology, Hospital Center of Porto, Porto, Portugal.
15Medical Faculty, Centre for Research in Health Technologies and Information Systems, Porto, Portugal.
Margarida Lima
5Department of Hematology, Hospital Center of Porto, Porto, Portugal.
6Multidisciplinary Unit for Biomedical Research, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Bernd Lepenies
16Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
17Immunology Unit and Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
Harry Sokol
4Sorbonne Université, INSERM, Saint-Antoine Research Center (CRSA), Paris, France.
18INRA, UMR1319 Micalis, AgroParisTech, Jouy-en-Josas, France.
19Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique - Hopitaux de Paris, Sorbonne Universités, Paris, France.
José C. Machado
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
12Faculty of Medicine, University of Porto, Porto, Portugal.
Manuel Vilanova
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
Salomé S. Pinho
1Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
12Faculty of Medicine, University of Porto, Porto, Portugal.
DOI: 10.1158/2326-6066.CIR-20-0264 Published November 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
November 2020
Volume 8, Issue 11
Volume 8, Issue 11
Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer Progression
Mariana C. Silva, Ângela Fernandes, Maria Oliveira, Carlos Resende, Alexandra Correia, Julio C. de-Freitas-Junior, Aonghus Lavelle, Jéssica Andrade-da-Costa, Magdalena Leander, Helena Xavier-Ferreira, José Bessa, Carina Pereira, Rui M. Henrique, Fátima Carneiro, Mário Dinis-Ribeiro, Ricardo Marcos-Pinto, Margarida Lima, Bernd Lepenies, Harry Sokol, José C. Machado, Manuel Vilanova and Salomé S. Pinho
Cancer Immunol Res November 1 2020 (8) (11) 1407-1425; DOI: 10.1158/2326-6066.CIR-20-0264
Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer Progression
Mariana C. Silva, Ângela Fernandes, Maria Oliveira, Carlos Resende, Alexandra Correia, Julio C. de-Freitas-Junior, Aonghus Lavelle, Jéssica Andrade-da-Costa, Magdalena Leander, Helena Xavier-Ferreira, José Bessa, Carina Pereira, Rui M. Henrique, Fátima Carneiro, Mário Dinis-Ribeiro, Ricardo Marcos-Pinto, Margarida Lima, Bernd Lepenies, Harry Sokol, José C. Machado, Manuel Vilanova and Salomé S. Pinho
Cancer Immunol Res November 1 2020 (8) (11) 1407-1425; DOI: 10.1158/2326-6066.CIR-20-0264
Jump to section
Advertisement